Skip to main content
RYAN logo

RYAN · Ryan Specialty Holdings, Inc.

Track RYAN — free
Market Cap
$11.19B
Shares
255.81M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$43.87 Open$43.69 Day$43.49–44.21 52W close$29.39–58.38 Avg vol 30d1.9M Short int13.2M · 5.2% float · 6.6d Short vol72% Last earningsJul 30, 2026 DataJul 2021–Aug 2026 Filing10-Q · Jul 31

Up next

Next earnings call
Oct 29, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 31, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Strong Sentiment Neutral Fundamentals Strong Quant / Vol High
      Market backdrop VIX 14.4 · calm Equity put/call 0.62
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +4%
      above
      Price vs 50-day avg +6%
      above
      RSI (14) 57
      neutral
      MACD trend Negative
      52-week position 50%
      mid-range
      Momentum
      relative strength
      Strong
      1-month return −1%
      trailing
      6-month return +16%
      trailing
      YTD return −15%
      this year
      Relative strength +3%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $42 › 200d $42 — 200d above 50d
      Institutional flow Accumulating
      +1% holders QoQ · +82 funds added
      Insider flow Accumulating
      Net +$4.5M over 90 days · 17% sells
      Short interest Rising
      5.17% of float · ▲ +0.3% MoM · 6.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      369 holders — mid 3-yr range
      Squeeze score 78
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +21%
      Y/Y
      Buyback $300.0M
      remaining
      Balance sheet $3.2B
      net debt
      Quant / Vol
      risk profile
      High
      Volatility 43%
      annualized · 1-yr
      Max drawdown −50%
      past year
      ATR 3.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Jun 30, 2026
      Gap interest expense, net of interest income on operating funds · 2026 GAAP $226M
      Prior guidance period ended · from the 8-K filed Jul 31, 2025
      Organic Revenue Growth Rate · full year 2025 9% – 11%
      Adjusted EBITDAC Margin · full year 2025 32.5% – 33%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +4% Bullish
      Price vs 50-day avg
      +6% Bullish
      RSI (14)
      57 Neutral
      MACD trend
      Negative Bearish
      52-week position
      50% Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $42 › 200d $42 — 200d above 50d
      Institutional flow Accumulating
      +1% holders QoQ · +82 funds added
      Insider flow Accumulating
      Net +$4.5M over 90 days · 17% sells
      Short interest Rising
      5.17% of float · ▲ +0.3% MoM · 6.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      369 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $29 Now $44 · 50% Range high $58
      vs 200-day avg +4% vs 50-day avg +6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Class A common stock repurchased 8.1M Q2 2026
      Share repurchase program authorization $300M As of June 30, 2026
      Cash returned to shareholders through repurchases $40M Three Months Ended March 31, 2026
      GAAP → non-GAAP reconciliation
      GAAP Adjusted EBITDAC 998.27M
      +48.39M Credit adjustments
      = Credit Adjusted EBITDAC 1.05B
      Remaining Share Repurchase Authorization $260M As of March 31, 2026
      Shares Repurchased 1M Q1 FY2026
      Adjusted diluted earnings per share diluted share count non-GAAP 279.03M Year Ended December 31, 2025
      Organic revenue growth non-GAAP 6.6% Q4 2025
      Organic revenue growth (Non-GAAP) non-GAAP 240.34M Year Ended December 31, 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Insurance - Specialty — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RYAN
      Ryan Specialty Holdings, Inc.
      this stock
      $11.19B -15.0% +21.3% 5.2%
      FNF
      Fidelity National Financial, Inc.
      $12.69B -12.9% +5.6% 3.1%
      FAF
      First American Financial Corp
      $7.61B +21.2% +21.6% 10.3 5.5%
      AXS
      Axis Capital Holdings Ltd
      $7.37B -7.1% +10.2% 7.5 2.8%
      ACT
      Enact Holdings, Inc.
      $6.75B +23.8% +2.8% 10.3 1.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      369
      % held
      45.7%
      Net QoQ
      +5.7M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      351
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      13.2M
      Days to cover
      6.6d
      Change
      +36.3K sh
      View
      Short Volume
      Short vol %
      72%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      16.2K
      Value
      $744.0K
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      40.0%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Cluster buy
      Net (90d)
      +$4.5M
      Buyers / Sellers
      5 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $3.1B
      Net income (FY)
      $63.4M
      View
      Buybacks
      Authorized
      $300.0M
      Remaining
      $300.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 7, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $86.3K
      Shares
      2.0K
      Filed
      Aug 13, 2026
      View
      Exempt Offerings
      Offering
      Indefinite
      Filed
      Dec 22, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      RYAN +1.4% -0.7% +15.9% -0.7% -15.0%
      SPY +0.5% +3.0% +13.4% +3.0% +12.8%
      vs SPY +0.9% -3.7% +2.5% -3.7% -27.9%

      Capital returns

      Latest dividend
      $0.13 / share · ex Aug 11, 2026
      Raised 8.3%
      Paid (TTM)
      $0.51 / share · 4 payouts
      Dividend yield (TTM, derived)
      1.16%
      Buyback program · as of Jun 30, 2026
      Authorized
      $300.00M
      Spent (derived)
      $0
      Remaining
      $300.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1849253 CUSIP 78351F107 13F (30d) 293 filings 277 filers Visit website Investor relations